Winnipeg, Canada

Jocelyn Entwistle

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Other. Active years: 2002.


% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 22(Granted Patents)


Company Filing History:

goldMedal1 out of 834,453 
Other
 patents

Years Active: 2002

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jocelyn Entwistle

Introduction

Jocelyn Entwistle is a notable inventor based in Winnipeg, Canada. He has made significant contributions to the field of biotechnology, particularly through his research on hyaluronan receptor proteins. His work has implications for understanding cell locomotion, motility, and proliferation.

Latest Patents

Jocelyn holds a patent for a novel hyaluronan receptor protein, designated as the Receptor for Hyaluronic Acid Mediated Motility, or RHAMM. This invention relates to the protein's role in cell locomotion and transformation, as well as the DNA sequences encoding this protein. His innovative approach has the potential to advance research in cellular behavior and therapeutic applications.

Career Highlights

Throughout his career, Jocelyn has focused on the intersection of molecular biology and biotechnology. His research has garnered attention for its potential applications in medical science, particularly in understanding cancer and other diseases related to cell movement and growth.

Collaborations

Jocelyn has worked alongside esteemed colleagues such as Eva Ann Turley and Shuwen Zhang. Their collaborative efforts have contributed to the advancement of knowledge in their field and have fostered a productive research environment.

Conclusion

Jocelyn Entwistle's contributions to the field of biotechnology through his patent on RHAMM exemplify the importance of innovation in understanding complex biological processes. His work continues to inspire future research and development in cellular biology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…